Status:
COMPLETED
The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension
Lead Sponsor:
Bayer
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is to asses the efficacy and safety of telmisartan, with the special attention on the influence of telmisartan on selected metabolic parameters of patients.
Eligibility Criteria
Inclusion
- Age over 18
- Untreated or ineffectively treated arterial hypertension
Exclusion
- Cholestatic disorders and severe hepatic failure
- Allergy to telmisartan
- Pregnancy and lactation period
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
5448 Patients enrolled
Trial Details
Trial ID
NCT00471003
Start Date
September 1 2006
End Date
November 1 2009
Last Update
January 20 2010
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Croatia
2
Many Locations, Poland
3
Many Locations, Slovakia
4
Many Locations, Slovenia